Latest Form 4 insider transactions

Behrad Derakhshan, Chief Business Officer of Edgewise Therapeutics, Inc., sold 5,100 shares of common stock on August 12, 2026.

Fazal F Merchant, a Director of Warner Bros. Discovery, Inc., sold 71,539 shares of common stock on August 13, 2026 for $27.75 per share.

John Min, Chief Legal Ofcr & Secretary of Wendy's Co, reported multiple transactions in common stock on August 12, 2026.

Kevin Koch, President and CEO and a Director of Edgewise Therapeutics, Inc., sold 17,971 shares of common stock on August 12, 2026.

Ban Seng Teh, EVP & Chief Commercial Officer of Seagate Technology Holdings plc, sold 7,361 shares of common stock on August 13, 2026.

Peter J. Suerken Jr, President, U.S. of Wendy's Co, reported multiple transactions in common stock on August 12, 2026.

Brian E Shore, Board Chairman & CEO and a Director of Park Aerospace Corp, sold 15,000 shares of common stock on August 12, 2026.

Richard W Fisher, a Director of Warner Bros. Discovery, Inc., sold 20,000 shares of common stock on August 12, 2026 for $27.46 per share.

Dafna Sarnoff, Chief Marketing Officer of CarGurus, Inc., sold 17,151 shares of common stock on August 13, 2026 for $37.00 per share.

Greg M Schwartz, a Director of CarGurus, Inc., sold 10,000 shares of common stock on August 12, 2026 for $36.07 per share.

Ryan J. Watts, President and CEO and a Director of Denali Therapeutics Inc., reported a transaction in 32,220 shares of common stock on August 12, 2026.

Nth Cycle, a critical mineral refining company, is set to combine with Kensington Capital Acquisition Corp. VI, aiming to build the West's refining capacity for essential minerals.

James L L Tullis, a Director of Crane Co, sold 614 shares of common stock on August 13, 2026 for $225.00 per share.

Randy J Taylor, See Remarks of US Foods Holding Corp., sold 11,630 shares of common stock on August 13, 2026.

Kevin Mark Wilson, Chief Executive Officer of Verb Technology Company, Inc., purchased 7,300 shares of common stock on August 13, 2026.

Alexander Otto, a Director of Curbline Properties Corp., sold 231,943 shares of common stock on August 12, 2026.

Cartesian Growth Corporation II and InoBat AS have publicly released an investor presentation detailing their proposed business combination, signaling a significant step towards a merger in the energy storage sector.

Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on August 12, 2026 for $7.52 per share.

Jay J Jackson, Chief Executive Officer, a Director and 10% owner of Abacus Life, Inc., sold 196,000 shares of common stock on August 12, 2026 for $8.77 per share.

Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 4,000 shares of common stock on August 13, 2026 for $7.52 per share.

Essential Utilities provides an update on its merger integration with American Water, confirming role selections for approximately 78% of the workforce and outlining next steps for organizational design.

Keith D Larson, General Counsel and Secretary of Venture Global, Inc., sold 555,555 shares of common stock on August 13, 2026 for $13.48 per share.

Sari Beth Granat, a Director of Venture Global, Inc., sold 200,000 shares of common stock on August 13, 2026 for $13.49 per share.

Jimmy D Staton, a Director of Venture Global, Inc., sold 66,000 shares of common stock on August 13, 2026 for $13.35 per share.

Thomas E Polen Jr, Chairman, CEO and President and a Director of Becton Dickinson & Co, sold 4,152 shares of common stock on August 13, 2026 for $185.00 per share.

Alaleh Nouri, EVP, CLO, CORP. SEC. of PROCEPT BioRobotics Corp, reported multiple transactions in common stock on August 13, 2026.

Paul Cahill Sciarra, a Director of Joby Aviation, Inc., sold 62,500 shares of common stock on August 13, 2026 for $7.96 per share.

Lisa Gimbel, CHIEF ACCOUNTING OFFICER of PubMatic, Inc., sold 500 shares of common stock on August 12, 2026 for $17.50 per share.

Daniel P Tredwell, a Director of Trimas Corp, purchased 64 shares of common stock on August 12, 2026 for $39.63 per share.

Ryan Fukushima, CEO, Data of Tempus AI, Inc., reported a transaction in 62,239 shares of common stock on August 12, 2026.